
non
US
Non-U.S./GlobalUS
Baron International Growth Fund
Symbol BIGFXCUSIP: 06828M306
Symbol BIGFXCUSIP: 06828M306
Nav
$35.19
Daily Change -$0.45 (-1.26%)
As of 10/07/2026
As of 10/07/2026
Net Assets
$322.94 M
As of 06/30/2026
Morningstar Rating™*
As of 09/30/2026
Inception date
12/31/2008
Prices & Performance
PricesAs of 10/07/2026
| NAV | Daily Change ($) | Daily Change (%) | MTD | QTD | YTD |
|---|---|---|---|---|---|
| $35.19 | -$0.45 | -1.26% | 0.09% | 0.09% | 12.12% |
| NAV | $35.19 |
|---|---|
| Daily Change ($) | -$0.45 |
| Daily Change (%) | -1.26% |
| MTD | 0.09% |
| QTD | 0.09% |
| YTD | 12.12% |
PerformanceAs of 09/30/2026
| Portfolio or Index | QTD1 | YTD1 | 1 Year | 3 Years | 5 Years | 10 Years | Since Inception 12/31/2008 |
|---|---|---|---|---|---|---|---|
| BIGFX - Baron International Growth Fund | -0.65% | 12.03% | 8.65% | 14.91% | 1.85% | 7.88% | 9.37% |
| MSCI ACWI ex USA Index | 0.48% | 14.22% | 20.00% | 20.54% | 9.55% | 9.25% | 8.49% |
| MSCI ACWI ex USA IMI Growth Index | -2.11% | 10.13% | 12.81% | 17.23% | 5.28% | 8.25% | 8.55% |
Performance InformationAs of 06/30/2026
| Performance statistics | 3 Years | 5 Years | 10 Years |
|---|---|---|---|
| Standard Deviation (%) | 14.27 | 16.98 | 16.41 |
| Sharpe Ratio | 0.53 | -0.11 | 0.39 |
| Alpha (%) | -4.95 | -6.68 | -1.11 |
| Beta | 0.97 | 1.04 | 1.02 |
| R-Squared (%) | 89.67 | 91.44 | 87.82 |
| Tracking Error (%) | 4.60 | 5.02 | 5.74 |
| Information Ratio | -1.39 | -1.40 | -0.20 |
| Upside Capture (%) | 89.44 | 90.84 | 99.41 |
| Downside Capture (%) | 121.16 | 124.10 | 105.70 |
Except for Standard Deviation and Sharpe Ratio, the performance based-characteristics above were calculated relative to the Baron International Growth Fund's(BIGFX) benchmark (MSCI ACWI ex USA Index). Performance statistics for additional periods will be provided on request. Source FactSet: SPAR.
Risk & Return06/30/2015 - 06/30/2025
1 Source: FactSet SPAR.
Portfolio Holdings & Characteristics
HoldingsAs of 09/30/2026
| Holding | Sector | % of Net Assets | |
|---|---|---|---|
Taiwan Semiconductor Manufacturing Company Limited Taiwan Semiconductor Manufacturing Company Limited (TSM), known as TSMC, is the world's largest independent semiconductor foundry, manufacturing chips on behalf of other companies. TSMC is the dominant force in leading-edge semiconductor foundry manufacturing, as it benefits from economies of scale and a superior cost structure. The company's successful track record of deploying new technology faster than competitors helps it maintain market share and pricing power. We believe TSMC’s investments in advanced nodes will strengthen its market leadership and support long-term profitability. | Information Technology | 6.1% | |
argenx SE Argenx SE (ARGX) is a biotechnology company launching Vyvgart (efgartigimod) in myasthenia gravis and chronic inflammatory demyelinating polyneuropathy, while developing the drug for additional autoantibody-driven autoimmune conditions. Efgartigimod has potentially broad applicability in ameliorating overactive antibody-based diseases. Efgartigimod is a true "pipeline in a product," where the product itself is the platform, as it has the potential to be used against a diverse range of diseases—something that is rarely achieved in the biotechnology space. We expect the share price to increase as argenx proves its product’s effectiveness in multiple autoantibody disorders. | Health Care | 3.6% | |
BNP Paribas S.A. BNP Paribas S.A. (BNP.FP) is a French bank with leading positions in France, Belgium, and Italy. It offers retail banking, corporate investment banking, and asset management, among other financial services. BNP has smaller operations throughout Europe, as well as in the U.S., through its subsidiary Bancwest. BNP offers a diversified earning mix, above-average execution track record, and high-quality management, in our view. It holds strong franchises in its three main activities: retail banking, corporate and institutional banking, and investment solutions—positioning it to benefit from an expected eventual recovery in the Eurozone. We think BNP will improve returns on equity (ROE) through increasing efficiencies. We also think there is upside to management’s strategic plan for achieving 12% ROE, as it is based on conservative assumptions on growth and interest rates. | Financials | 2.9% | |
Samsung Electronics Co., Ltd. Samsung Electronics Co., Ltd. (005930.KS) is a Korean technology conglomerate known for its leadership in consumer electronics and semiconductor manufacturing. Samsung is the bellwether for global technology innovation and continues to deliver robust earnings across memory, logic, display, and smartphones. We are confident Samsung can maintain its technology leadership for years to come, given its strong research and development track record and ability to meet ever-changing global consumer demand. | Information Technology | 2.4% | |
TotalEnergies SE TotalEnergies SE (TTE.FP) is a global integrated energy company that produces, refines, and markets oil, natural gas, and LNG, and generates and sells electricity. Present in nearly 120 countries, it is one of the world's largest LNG suppliers and a growing producer of low-carbon power. TotalEnergies is one of the largest and lowest cost producers of liquefied natural gas (LNG), with an industry leading project pipeline and global marketing network. Disciplined capital allocation has delivered the highest return on capital employed among the integrated majors, and low-geared balance sheet supports a growing dividend and consistent buybacks through the cycle. We view favorably its integrated power build-out, including long-term contracts with data center customers and its targets to cut Scope 1 and 2 emissions by 40% by 2030 and reach net-zero by 2050. | Energy | 2.4% | |
Keyence Corporation Keyence Corporation (6861.JP) develops sensors, machine vision systems, and precision measurement equipment for factory automation. Headquartered in Osaka, Japan, it serves manufacturers through a direct-sales network spanning 46 countries. Keyence is a leading supplier of sensors and machine vision for factory automation, benefiting as labor shortages, wage inflation, and reshoring increase automation intensity. Its innovation engine—70% of new products feature world- or industry-first technology—direct-sales model, and fabless manufacturing support strong margins through cycles. A modest market share leaves a long runway, while AI-related investment provides an additional tailwind. We expect earnings to compound at a low- to mid-teens rate over the next three to five years. | Information Technology | 2.2% | |
Arch Capital Group Ltd. Arch Capital Group Ltd. (ACGL) is a Bermuda-based insurance company providing property and casualty insurance, reinsurance, and mortgage insurance. Arch is led by an experienced management team with a successful track record across insurance cycles. The company excels at underwriting specialized policies and can nimbly shift its business mix to target the most profitable lines as market conditions change. With only 2% share of a $1 trillion global commercial insurance market, Arch has significant runway for share gains. Management has demonstrated strong underwriting discipline and capital stewardship, allowing Arch to maintain industry-leading returns on equity with less volatility than peers. | Financials | 2.1% | |
Japan Exchange Group, Inc. Japan Exchange Group, Inc. | Financials | 2.0% | |
Agilent Technologies, Inc. Agilent Technologies, Inc. (A) is the world’s largest supplier of test and measurement hardware and software products to the electronics, life sciences, chemical analysis, and diagnostics industries. The company plans to separate into two publicly traded companies in November 2014. The company's business mix has been shifting towards more stable life sciences, chemical analysis and diagnostics markets, with these end markets now representing over 50% of sales, and away from the more cyclical electronics measurement market. Management's recent decision to separate into two independent public companies, one focused on life sciences, diagnostics and chemical analysis, and the other focused on electronic measurement, should, in our view, create long-term shareholder value. | Health Care | 1.9% | |
Linde Plc Linde plc (LIN.GY) is the largest global independent industrial gas operator. Industrial gas producers benefit from strong pricing power due to the industry's consolidated structure and high barriers to entry. We believe Linde will also benefit from global decarbonization efforts and increased gas intensity trends driven by industrial innovation, which can create new project opportunities. We expect these drivers to supplement double-digit earnings growth in the company’s core industrial gas business. | Materials | 1.9% | |
Total | 27.6% |
Top Ten Fund Holdings based on net assets. Portfolio holdings may change over time.
Portfolio holdings are subject to change. Current and future portfolio holdings are subject to risk.
Portfolio holdings are subject to change. Current and future portfolio holdings are subject to risk.
Contributors / DetractorsQuarterly as of 06/30/2026
| Top Contributors | Average Weight | Contribution |
|---|---|---|
| Taiwan Semiconductor Manufacturing Company Limited | 5.96% | 1.91% |
| Tokyo Electron Limited | 2.44% | 1.65% |
| SK hynix Inc. | 1.51% | 1.49% |
| Samsung Electronics Co., Ltd. | 2.25% | 1.36% |
| Montage Technology Co., Ltd. | 0.97% | 0.92% |
Source: FactSet PA.
GICS Sector BreakdownAs of 09/30/2026
Sector
Information Technology
23.7%
Financials
20.0%
Health Care
14.4%
Industrials
13.8%
Materials
6.7%
Consumer Discretionary
6.2%
Energy
4.5%
Communication Services
3.5%
Consumer Staples
3.0%
Cash and Cash Equivalents
2.8%
Utilities
1.1%
Real Estate
0.4%
Diversified Banks10.0%
Semiconductors9.7%
Life Sciences Tools & Services7.7%
Biotechnology4.3%
Financial Exchanges & Data3.9%
Semiconductor Materials & Equipment 3.7%
Aerospace & Defense3.6%
Investment Banking & Brokerage2.7%
Packaged Foods & Meats2.6%
Construction Machinery & Heavy Transportation Equipment 2.4%
Integrated Oil & Gas2.4%
Technology Hardware, Storage & Peripherals2.4%
Electronic Equipment & Instruments2.2%
Property & Casualty Insurance2.1%
Apparel Retail2.0%
0246810
Diversified Banks10.0%
Semiconductors9.7%
Life Sciences Tools & Services7.7%
Biotechnology4.3%
Financial Exchanges & Data3.9%
Semiconductor Materials & Equipment 3.7%
Aerospace & Defense3.6%
Investment Banking & Brokerage2.7%
Packaged Foods & Meats2.6%
Construction Machinery & Heavy Transportation Equipment 2.4%
Integrated Oil & Gas2.4%
Technology Hardware, Storage & Peripherals2.4%
Electronic Equipment & Instruments2.2%
Property & Casualty Insurance2.1%
Apparel Retail2.0%
0246810
Japan14.7%
France12.1%
India9.3%
United States7.6%
Taiwan7.4%
Korea6.8%
Netherlands5.5%
China5.5%
United Kingdom4.5%
Canada4.3%
Sweden2.9%
Switzerland2.7%
Germany2.6%
Ireland1.8%
Spain1.8%
Greece1.5%
Brazil1.3%
Finland1.2%
Italy1.1%
Argentina0.9%
Peru0.8%
Israel0.4%
Australia0.3%
Chile0.2%
03691215
Japan14.7%
France12.1%
India9.3%
United States7.6%
Taiwan7.4%
Korea6.8%
Netherlands5.5%
China5.5%
United Kingdom4.5%
Canada4.3%
Sweden2.9%
Switzerland2.7%
Germany2.6%
Ireland1.8%
Spain1.8%
Greece1.5%
Brazil1.3%
Finland1.2%
Italy1.1%
Argentina0.9%
Peru0.8%
Israel0.4%
Australia0.3%
Chile0.2%
03691215
Portfolio CharacteristicsAs of 06/30/2026
| Description | Baron International Growth Fund | MSCI ACWI ex USA Index |
|---|---|---|
| Inception Date | December 31, 2008 | |
| Net Assets | $322.94 million | |
| # of Issuers / % of Net Assets | 92/97.0% | |
| Turnover (3 Year Average) | 30.78% | |
| Active Share | 82.7% | |
| Median Market Cap | $20.52 billion | $15.03 billion |
| Weighted Average Market Cap | $311.91 billion | $297.01 billion |
| Gross Expense Ratio | 1.26% | |
| Net Expense Ratio | 1.21% | |
| As of FYE Current Expense Ratio Date | 04/30/2026 | |
| EPS Growth (3-5 year forecast) | 13.9% | 14.9% |
| Price/Earnings Ratio (trailing 12-month) | 22.2x | 18.4x |
| Price/Book Ratio | 3.2x | 2.3x |
| Price/Sales Ratio | 2.8x | 1.8x |
The Net Assets include all share classes combined.
Price/Book Ratio and Price/Sales Ratio are calculated using the Weighted Harmonic Average. Source: FactSet PA. Internal valuation metrics may differ.
Price/Book Ratio and Price/Sales Ratio are calculated using the Weighted Harmonic Average. Source: FactSet PA. Internal valuation metrics may differ.
Distributions
| Record Date | Ex Date | Payable Date | Income | Return of Capital | Short-Term Capital Gain | Long-Term Capital Gain | Total | Re-Invest NAV | Calendar-Year Return |
|---|---|---|---|---|---|---|---|---|---|
| 09/21/2026 | 09/22/2026 | 09/23/2026 | $0.1200 | $0.0000 | $0.0000 | $0.0000 | $0.1200 | $35.88 | |
| 12/15/2025 | 12/16/2025 | 12/17/2025 | $0.2670 | $0.0000 | $0.0000 | $0.0000 | $0.2670 | $30.93 | 20.81% |
| 12/16/2024 | 12/17/2024 | 12/18/2024 | $0.1808 | $0.0000 | $0.0000 | $0.0000 | $0.1808 | $26.73 | 4.11% |
| 09/23/2024 | 09/24/2024 | 09/25/2024 | $0.0307 | $0.0000 | $0.0000 | $0.0000 | $0.0307 | $27.68 | 4.11% |
| 12/06/2023 | 12/07/2023 | 12/08/2023 | $0.0897 | $0.0000 | $0.0000 | $0.0000 | $0.0897 | $24.34 | 7.33% |
For estimated distributions, visit the Tax Center